Literature DB >> 2995430

The in vitro regulation of human thyrocyte HLA-DR antigen expression.

A P Weetman, D J Volkman, K D Burman, T L Gerrard, A S Fauci.   

Abstract

The ability of endocrine organs to express human immune response-associated antigens (Ia), such as HLA-DR, is a subject of intense current interest. In this study, the effects of various potential modulators of thyroid follicular cell HLA-DR expression were examined using in vitro cultures. A culture supernatant containing T-cell-derived lymphokines caused DR antigen expression on 13-18% of thyroid cells; more consistent effects were produced by recombinant gamma-interferon, which led to 46-100% of the thyroid cells becoming HLA-DR positive after 3 days in culture. This effect was both time and concentration dependent and occurred in thyroid cells derived from patients with Graves' disease (n = 7) and Hashimoto's thyroiditis (n = 2) as well as from three subjects with no autoimmune thyroid disease. Thyroid cells stained with the monoclonal antibodies 4F2 and 5E9, which recognize cell activation antigens, regardless of whether they were treated with gamma-interferon. The lectin phytohemagglutinin also induced HLA-DR antigen expression (21-91% of cells positive). This response was dependent on T cell contamination of thyroid cell suspensions, since the effect was inhibited by cyclosporin A. HLA-DQ antigen expression, identified by the Leu-10 monoclonal antibody, was also induced on thyroid cells by gamma-interferon and phytohemagglutinin. In contrast, neither recombinant alpha-interferon nor interleukin-2 induced HLA-DR antigens. Irradiation reduced the response of thyroid cells to gamma-interferon, but two of the known inhibitors of macrophage Ia expression, prostaglandin E2 and (Bu)2cAMP, did not affect gamma-interferon-induced thyroid cell HLA-DR expression. We were unable to detect interleukin-1 production by thyroid cells. These results suggest that 1) under normal circumstances, thyroid cells are 4F2 and 5E9 positive, but are incapable of expressing Ia antigens and, thus, of activating T cells to initiate autoimmune thyroiditis; and 2) once activated, for example by a virus, T cells could release gamma-interferon and induce thyroid cell HLA-DR and -DQ antigen expression; these Ia-positive thyroid cells could then have a role in maintaining or enhancing the autoimmune response.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2995430     DOI: 10.1210/jcem-61-5-817

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  28 in total

1.  Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone.

Authors:  I Todd; R Pujol-Borrell; L J Hammond; J M McNally; M Feldmann; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

2.  Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes.

Authors:  S L Saidman; R J Duquesnoy; A Zeevi; J J Fung; T E Starzl; A J Demetris
Journal:  Hepatology       Date:  1991-02       Impact factor: 17.425

3.  Induction of HLA-DR antigen expression in human endometrial epithelial cells in vitro by recombinant gamma-interferon.

Authors:  S S Tabibzadeh; M A Gerber; P G Satyaswaroop
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

4.  T cell receptor phenotypes in autoimmune thyroid disease.

Authors:  W P Teng; S B Cohen; D N Posnett; A P Weetman
Journal:  J Endocrinol Invest       Date:  1990-04       Impact factor: 4.256

Review 5.  Regulation and role of thyroid cell class II antigen expression.

Authors:  A P Weetman
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

6.  Suppression of HLA class II expression on thyrocytes by interferon-alpha 1.

Authors:  V Guerin; I Todd; L J Hammond; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

7.  Immunological events leading to destructive thyroiditis in the AUG rat.

Authors:  R Hassman; N Solic; B Jasani; R Hall; A M McGregor
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

8.  The remarkable proliferation of helper T cell subset in response to autologous thyrocytes and intrathyroidal T cells from patients with Graves' disease.

Authors:  K Eguchi; T Otsubo; Y Kawabe; Y Ueki; T Fukuda; M Matsunaga; C Shimomura; N Ishikawa; H Tezuka; H Nakao
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

9.  Synergy in antigen presentation by thyroid epithelial cells and monocytes from patients with Graves' disease.

Authors:  K Eguchi; T Otsubo; Y Kawabe; C Shimomura; Y Ueki; H Nakao; H Tezuka; M Matsunaga; T Fukuda; N Ishikawa
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

10.  HLA-G does not have a pathophysiological role in Graves' disease.

Authors:  E H Kemp; R A Metcalfe; P F Watson; A P Weetman
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.